191 related articles for article (PubMed ID: 16075611)
1. [A role of growth factors in development of various histological types of uterine leiomyoma].
Kogan EA; Ignatova VE; Rukhadze TN; Kudrina EA; Ishchenko AI
Arkh Patol; 2005; 67(3):34-8. PubMed ID: 16075611
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of SPRM asoprisnil (J867) on proliferation, apoptosis, and the expression of growth factors in cultured uterine leiomyoma cells and normal myometrial cells.
Ohara N; Morikawa A; Chen W; Wang J; DeManno DA; Chwalisz K; Maruo T
Reprod Sci; 2007 Dec; 14(8 Suppl):20-7. PubMed ID: 18089606
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta and platelet-derived growth factor in human myometrium and in uterine leiomyomas at various stages of tumour growth.
Wolańska M; Bańkowski E
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):238-44. PubMed ID: 16564125
[TBL] [Abstract][Full Text] [Related]
4. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells.
Wang J; Ohara N; Wang Z; Chen W; Morikawa A; Sasaki H; DeManno DA; Chwalisz K; Maruo T
Hum Reprod; 2006 Jul; 21(7):1869-77. PubMed ID: 16613890
[TBL] [Abstract][Full Text] [Related]
5. Expression of chemokines CCL5 and CCL11 by smooth muscle tumor cells of the uterus and its possible role in the recruitment of mast cells.
Zhu XQ; Lv JQ; Lin Y; Xiang M; Gao BH; Shi YF
Gynecol Oncol; 2007 Jun; 105(3):650-6. PubMed ID: 17368523
[TBL] [Abstract][Full Text] [Related]
6. In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/intracrine mechanism.
Sumitani H; Shozu M; Segawa T; Murakami K; Yang HJ; Shimada K; Inoue M
Endocrinology; 2000 Oct; 141(10):3852-61. PubMed ID: 11014242
[TBL] [Abstract][Full Text] [Related]
7. Sex steroidal regulation of uterine leiomyoma growth and apoptosis.
Maruo T; Ohara N; Wang J; Matsuo H
Hum Reprod Update; 2004; 10(3):207-20. PubMed ID: 15140868
[TBL] [Abstract][Full Text] [Related]
8. [Affect of insulin-like growth factor I and estradiol on the growth of uterine leiomyoma].
Huang J; Zou J; Xu B; Zhang Y; Chen X; Liu D
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):29-32. PubMed ID: 11938733
[TBL] [Abstract][Full Text] [Related]
9. Growth factors and pathogenesis.
Islam MS; Greco S; Janjusevic M; Ciavattini A; Giannubilo SR; D'Adderio A; Biagini A; Fiorini R; Castellucci M; Ciarmela P
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():25-36. PubMed ID: 26527305
[TBL] [Abstract][Full Text] [Related]
10. [Study of the mechanism of mast cell increase in cellular leiomyoma of uterus].
Lü JQ; Zhu XQ; Dong K; Xiang M; Lin Y; Hu Y
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):390-3. PubMed ID: 17697600
[TBL] [Abstract][Full Text] [Related]
11. [Correlation between proliferation and apoptosis in different histological types of uterine leiomyoma].
Kogan EA; Ignatova VE; Unania AL; Sidorova IS
Arkh Patol; 2005; 67(4):32-6. PubMed ID: 16209296
[TBL] [Abstract][Full Text] [Related]
12. [The morphofunctional characteristics of proteins of nucleolar organizers in uterine smooth muscle tumors].
Bobrov IP; Avdalian AM; Lazarev AF; Klimachev VV; Klimacheva TB; Mishchenko EV
Arkh Patol; 2008; 70(3):18-23. PubMed ID: 18727427
[TBL] [Abstract][Full Text] [Related]
13. Expression of terminally glycosylated calcitonin receptor-like receptor in uterine leiomyoma: endothelial phenotype and association with microvascular density.
Nikitenko LL; Cross T; Campo L; Turley H; Leek R; Manek S; Bicknell R; Rees MC
Clin Cancer Res; 2006 Oct; 12(19):5648-58. PubMed ID: 17020966
[TBL] [Abstract][Full Text] [Related]
14. [Basic fibroblast growth factor in leiomyoma].
Wolańska M; Sobolewski K
Pol Merkur Lekarski; 2004 Dec; 17(102):590-2. PubMed ID: 15771129
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific efficacy of transforming growth factor-beta RI inhibition in Eker rats.
Laping NJ; Everitt JI; Frazier KS; Burgert M; Portis MJ; Cadacio C; Gold LI; Walker CL
Clin Cancer Res; 2007 May; 13(10):3087-99. PubMed ID: 17505012
[TBL] [Abstract][Full Text] [Related]
16. An accumulation of insulin-like growth factor I (IGF-I) in human myometrium and uterine leiomyomas in various stages of tumour growth.
Wolańska M; Bańkowski E
Eur Cytokine Netw; 2004; 15(4):359-63. PubMed ID: 15627646
[TBL] [Abstract][Full Text] [Related]
17. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
Luo X; Levens E; Williams RS; Chegini N
Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
[TBL] [Abstract][Full Text] [Related]
18. Does vascular endothelial growth factor participate in uterine myoma growth stimulation?
Wolańska M; Małkowski A; Romanowicz L; Bańkowski E
Eur J Obstet Gynecol Reprod Biol; 2012 Sep; 164(1):93-7. PubMed ID: 22633778
[TBL] [Abstract][Full Text] [Related]
19. Selective progesterone receptor modulator asoprisnil induces endoplasmic reticulum stress in cultured human uterine leiomyoma cells.
Xu Q; Ohara N; Liu J; Nakabayashi K; DeManno D; Chwalisz K; Yoshida S; Maruo T
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1002-11. PubMed ID: 17652152
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of leiomyoma cell proliferation in vitro by genistein and the protein tyrosine kinase inhibitor TKS050.
Shushan A; Ben-Bassat H; Mishani E; Laufer N; Klein BY; Rojansky N
Fertil Steril; 2007 Jan; 87(1):127-35. PubMed ID: 17074332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
